[Disclosure] Celltrion (068270) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2025-09-23
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion’s 100% US subsidiary, Celltrion USA, Inc., has decided to acquire a 100% equity stake in Imclone Systems LLC from Eli Lilly Group for approx. KRW 460.0B (USD 330M) to establish a local US API manufacturing base. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s…